Related references
Note: Only part of the references are listed.Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study
Andrea Salzano et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease
Marco Busnelli et al.
NUTRIENTS (2020)
The Gut Axis Involvement in Heart Failure Focus on Trimethylamine N-oxide
Andrea Salzano et al.
HEART FAILURE CLINICS (2020)
Cardiac Cachexia Revisited The Role of Wasting in Heart Failure
Miroslava Valentova et al.
HEART FAILURE CLINICS (2020)
Ethnic differences in association of outcomes with trimethylamine N-oxide in acute heart failure patients
Yoshiyuki Yazaki et al.
ESC HEART FAILURE (2020)
Impact of acute choline loading on circulating trimethylamine N-oxide levels
Shabana Cassambai et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes
Xinmin S. Li et al.
EUROPEAN HEART JOURNAL (2019)
Geographical location affects the levels and association of trimethylamine N-oxide with heart failure mortality in BIOSTAT-CHF: a post-hoc analysis
Yoshiyuki Yazaki et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Sarcopenia: A Time for Action. An SCWD Position Paper
Juergen Bauer et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure
Tomohiro Hayashi et al.
CIRCULATION JOURNAL (2019)
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF
Toru Suzuki et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice
Wei-Kai Wu et al.
GUT (2019)
Dietary metabolism, the gut microbiome, and heart failure
W. H. Wilson Tang et al.
NATURE REVIEWS CARDIOLOGY (2019)
L-Carnitine and heart disease
Zhong-Yu Wang et al.
LIFE SCIENCES (2018)
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction
Toru Suzuki et al.
CLINICAL CHEMISTRY (2017)
Mitochondrial function as a therapeutic target in heart failure
David A. Brown et al.
NATURE REVIEWS CARDIOLOGY (2017)
Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction
Katharina Schuett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies
Katie A. Meyer et al.
NUTRIENTS (2017)
Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Xiaolong Song et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Prognostic Role of Molecular Forms of B-Type Natriuretic Peptide in Acute Heart Failure
Toru Suzuki et al.
CLINICAL CHEMISTRY (2017)
The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis
Karolina Skagen et al.
ATHEROSCLEROSIS (2016)
Trimethylamine N-oxide and prognosis in acute heart failure
Toru Suzuki et al.
HEART (2016)
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
M. Troseid et al.
JOURNAL OF INTERNAL MEDICINE (2015)
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Robert A. Koeth et al.
CELL METABOLISM (2014)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Gut microbiota metabolism of L-carnitine and cardiovascular risk
John R. Ussher et al.
ATHEROSCLEROSIS (2013)
Mechanisms underlying the anti-wasting effect of l-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies
Robert Ringseis et al.
EUROPEAN JOURNAL OF NUTRITION (2013)
Mitochondrial dysfunction in heart failure
Mariana G. Rosca et al.
HEART FAILURE REVIEWS (2013)
Disturbed carnitine regulation in chronic heart failure - Increased plasma levels of palmitoyl-carnitine are associated with poor prognosis
Thor Ueland et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart
Helene Lemieux et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines Program
Pamela N. Peterson et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
William T. Abraham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis
GC Fonarow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
